日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia

吉妥珠单抗奥佐米星 (GO) 加入诱导化疗可消除白血病起始细胞并显著提高急性髓系白血病小鼠模型的生存率

Cathy C Zhang, Zhengming Yan, Bernadette Pascual, Amy Jackson-Fisher, Donghui Stephen Huang, Qing Zong, Mark Elliott, Conglin Fan, Nanni Huser, Joseph Lee, Matthew Sung, Puja Sapra

Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth

肿瘤衍生的 EZH2 获得功能突变引起的表观遗传重编程促进了侵袭性的 3D 细胞形态并增强了黑色素瘤肿瘤的生长

Anthony M Barsotti, Michael Ryskin, Wenyan Zhong, Wei-Guo Zhang, Andreas Giannakou, Christine Loreth, Veronica Diesl, Maximillian Follettie, Jonathon Golas, Michelle Lee, Timothy Nichols, Conglin Fan, Gang Li, Stephen Dann, Valeria R Fantin, Kim Arndt, Dominique Verhelle, Robert A Rollins